Santhera Pharmaceuticals Holding Financial Overview
Santhera Pharmaceuticals Holding's market cap is currently CHF172.13M. The company's EPS TTM is CHF-3.04; its P/E ratio is -2.51; Santhera Pharmaceuticals Holding is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
